Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
E-pub ahead of print

Biological and small molecule strategies in migraine therapy with relation to the calcitonin gene-related peptide family of peptides

Publikation: Bidrag til tidsskriftReviewForskningpeer review

DOI

  1. Metabolic control and sex: A focus on inflammatory-linked mediators

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  2. Different mechanisms involved in liraglutide and glucagon-like peptide-1 vasodilatation in rat mesenteric small arteries

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Characterization of binding, functional activity, and contractile responses of the selective 5-HT1F receptor agonist lasmiditan

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. CGRP-dependent signalling pathways involved in mouse models of GTN- cilostazol- and levcromakalim-induced migraine

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Hormonal influences in migraine - interactions of oestrogen, oxytocin and CGRP

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  3. CGRP and migraine; from bench to bedside

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  4. Pre-Chiasmatic, Single Injection of Autologous Blood to Induce Experimental Subarachnoid Hemorrhage in a Rat Model

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

Migraine is one of the most common of neurological disorders with a global prevalence of up to 15%. One in five migraineurs have frequent episodic or chronic migraine requiring prophylactic treatment. In recent years, specific pharmacological treatments targeting calcitonin gene-related peptide (CGRP) signalling molecules have provided safe and effective treatments, monoclonal antibodies for prophylaxis and gepants for acute therapy. Albeit beneficial, it is important to understand the molecular mechanisms of these new drugs to better understand migraine pathophysiology and improve therapy. Here, we describe current views on the role of the CGRP family of peptides - CGRP, calcitonin, adrenomedullin, amylin - and their receptors in the trigeminovascular system. All these molecules are present within the trigeminovascular system but differ in expression and localization. It is likely that they have different roles, which can be utilized in providing additional drug targets.

OriginalsprogEngelsk
TidsskriftBritish Journal of Pharmacology
ISSN0007-1188
DOI
StatusE-pub ahead of print - 19 aug. 2021

ID: 67198162